Le Lézard
Classified in: Covid-19 virus
Subjects: Conference, Trade Show

The American Journal of Managed Care® Announces Patient-Centered Oncology Care® 2020 Conference to Be Held Virtually


The American Journal of Managed Care® (AJMC®), the leading multimedia peer-reviewed journal dedicated to issues in managed care, announces the Patient-Centered Oncology Care® (PCOC) 2020 conference will be transitioning to a virtual format on Sept. 25, to ensure safety amid the global pandemic.

"Unprecedented times call for extra effort and new innovative approaches," said Michael J. Hennessy Jr., president of MJH Life Sciencestm, parent company of AJMC®. "The health and safety of our attendees are of the utmost importance to AJMC®, and that is why we have made the decision to transition our annual conference to a live virtual format. We look forward to delivering an exceptional interactive experience for participants at this year's PCOC conference."

This year at PCOC, Alexandra Chong, Ph.D., health insurance specialist for the Center for Medicare & Medicaid Innovation (CMMI), Centers for Medicare & Medicaid Services (CMS), will give the keynote presentation on the Oncology Care Model (OCM), focusing on how the impact of the COVID-19 Public Health Emergency on patient care and the development of updates to model policies. Industry leaders such as Natalie Dickson, M.D.; Aaron Lyss, MBA; Terrill Jordan; David M. Jackman, M.D.; Lee Schwartzberg, M.D., FACP; Karen Marie Winkfield, M.D., Ph.D.; Robert Daly, M.D., MBA; and Karen K. Fields, M.D., will then dive deeper in several panel discussions surrounding the future of value-based care as it relates to precision health, biosimilars, health care disparities, chronic care management, policy, technology and more. Attendees will also have the opportunity to mingle with their peers and engage with leaders from payer, community, academic and patient advocacy groups on critical issues in oncology value-based care in the virtual networking lounge.

For more information and to view the agenda or register, click here.

About?The American Journal of Managed Care®

The American Journal of Managed Care®?(AJMC®) is a multimedia, peer-reviewed, MEDLINE-indexed journal that keeps industry leaders on the forefront of health policy by sharing digital research relevant to industry decision makers. Other brands in the?AJMC®?family include?The American Journal of Accountable Care®,?Evidence-Based Oncologytm and?Evidence-Based Diabetes Managementtm. These comprehensive multimedia brands bring together stakeholder views from payers, providers, policymakers and other industry leaders in managed care. AJMC® is a brand of MJH Life Sciencestm, the largest privately held, independent, full-service medical media company in North America, dedicated to delivering trusted health care news across multiple channels.


These press releases may also interest you

at 04:33
Uxin Limited ("Uxin" or the "Company") , China's leading used car retailer, today announced its unaudited financial results for the third quarter ended December 31, 2023. Highlights for the Quarter Ended December 31, 2023 Transaction volume was...

at 03:45
Phoenix Motor Inc. (the "Company"), a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicles, today announced it signed a waiver agreement with JAK Opportunities II LLC, one of the...

at 03:05
Vagaro, the leading international salon and spa software, and Jack Mead, award-winning hair stylist, salon owner, and educator, officially announced the release of their highly-anticipated Master Class series, delivering expert insights on using the...

at 02:30
Allied Market Research published a report, titled, "Pension Administration Software Market by Component (Solution and Services), Deployment Mode (On-Premise and Cloud), Type (Public Pension and Private Pension), End User (Employers, Pension Plan...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...



News published on and distributed by: